SurModics, Inc. (NASDAQ:SRDX)
CAPS Rating:
Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.
The World's Greatest Investing Community
Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Still has 5 potential opthamology deals to be signed in addition to Merck. Diverse portfolio of customes and products. Great patent coverage. No debt. Recent stock buyback. High short interest due to investors who feel Surmodics is a one trick pony with stents.